Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid

被引:32
作者
Vannini, Federica [1 ]
MacKessack-Leitch, Andrew C. [1 ,2 ]
Eschbach, Erin K. [1 ]
Chattopadhyay, Mitali [1 ]
Kodela, Ravinder [1 ]
Kashfi, Khosrow [1 ,3 ]
机构
[1] CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA
[2] Univ St Andrews, EaStCHEM Sch Chem, St Andrews KY16 9ST, Fife, Scotland
[3] Avicenna Pharmaceut Inc, New York, NY 10019 USA
基金
美国国家卫生研究院;
关键词
Nitric oxide; Hydrogen sulfide; NOSH-aspirin; Colon cancer; Cell kinetics; Reactive oxygen species; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; CANCER; GENERATION; AGENTS;
D O I
10.1016/j.bmcl.2015.08.023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We recently reported the synthesis of NOSH-aspirin, a novel hybrid compound capable of releasing both nitric oxide (NO) and hydrogen sulfide (H2S). In NOSH-aspirin, the two moieties that release NO and H2S are covalently linked at the 1, 2 positions of acetyl salicylic acid, i.e., ortho-NOSH-aspirin. Here we report on the synthesis of meta-and para-NOSH-aspirins. We also made a head-to-head evaluation of the effects of these three positional isomers of NOSH-aspirin on colon cancer cell kinetics and induction of reactive oxygen species, which in recent years has emerged as a key event in causing cancer cell regression. Electron donating/withdrawing groups incorporated about the benzoate moiety significantly affected the potency of these compounds with respect to colon cancer cell growth inhibition. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4677 / 4682
页数:6
相关论文
共 26 条
[1]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[2]   Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial [J].
Benamouzig, R ;
Deyra, J ;
Martin, A ;
Girard, B ;
Jullian, E ;
Piednoir, B ;
Couturier, D ;
Coste, T ;
Little, J ;
Chaussade, S .
GASTROENTEROLOGY, 2003, 125 (02) :328-336
[3]   NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model [J].
Chattopadhyay, Mitali ;
Kodela, Ravinder ;
Olson, Kenneth R. ;
Kashfi, Khosrow .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 419 (03) :523-528
[4]   Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs [J].
Fiorucci, S ;
Antonelli, E ;
Distrutti, E ;
Rizzo, G ;
Mencarelli, A ;
Orlandi, S ;
Zanardo, R ;
Renga, B ;
Di Sante, M ;
Morelli, A ;
Cirino, G ;
Wallace, JL .
GASTROENTEROLOGY, 2005, 129 (04) :1210-1224
[5]  
Fonesca M. D., 2015, PHARMACOL RES PERSPE, V3, P1
[6]   Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway [J].
Hanif, R ;
Pittas, A ;
Feng, Y ;
Koutsos, MI ;
Qiao, L ;
StaianoCoico, L ;
Shiff, SI ;
Rigas, B .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (02) :237-245
[7]   A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence [J].
Jacobs, EJ ;
Rodriguez, C ;
Mondul, AM ;
Connell, CJ ;
Henley, SJ ;
Calle, EE ;
Thun, MJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (13) :975-980
[8]  
Kashfi K, 2009, ADV PHARMACOL, V57, P31, DOI 10.1016/S1054-3589(08)57002-5
[9]   The role of oxidative stress in chemical carcinogenesis [J].
Klaunig, JE ;
Xu, Y ;
Isenberg, JS ;
Bachowski, S ;
Kolaja, KL ;
Jiang, JZ ;
Stevenson, DE ;
Walborg, EF .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 :289-295
[10]  
Kodela R., 2012, J MED CHEM, V8, P257